Sunday, December 7, 2025
No Result
View All Result
Volume 2, Issue 2
International Myeloma Society
  • Home
  • Letter From the President
  • COVID Corner
  • Research Spotlight
  • Meeting Updates
  • Contact
  • Home
  • Letter From the President
  • COVID Corner
  • Research Spotlight
  • Meeting Updates
  • Contact
No Result
View All Result
International Myeloma Society
No Result
View All Result
Home Quiz

Quiz 2

November 24, 2021
in Quiz

A 55-year-old male presented with easy bruising and recurrent nose bleeds.

He had mild anemia with Hb of 7.2 mM, and extensive laboratory work-up showed the presence of an IgM-kappa M-protein of 41 g/l (normal levels of the free light chains), as well as a coagulation tests compatible with acquired von Willebrand’s disease (low VWF antigen, even lower VWF activity, low FVIII, decrease in HMW VWF multimers, and presence of an inhibitory antibody in neutralization assays). There were no signs of hyperviscosity.

Whole body CT showed no abnormalities. Bone marrow examination revealed 25% clonal plasma cells. Cytogenetic evaluation showed hyperdiploidy in the clonal plasma cells, and molecular tests showed no MYD88 mutation. There were no other laboratory abnormalities.

    How would you treat this patient with acquired von Willebrand’s disease?

    Sign Up to Our Newsletter

    Popular Articles

    • Labs around the World: the MM Group at Mayo Clinic, Arizona

      Labs around the World: the MM Group at Mayo Clinic, Arizona

      0 shares
      Share 0 Tweet 0
    • International Myeloma Society (IMS) and Paula and Rodger Riney Foundation Translational Research Award

      0 shares
      Share 0 Tweet 0
    • CASSIOPEIA Maintenance

      0 shares
      Share 0 Tweet 0
    • HOVON 143 Study

      0 shares
      Share 0 Tweet 0
    • Picture of the Issue – ‘Serene’

      0 shares
      Share 0 Tweet 0
    • Home
    • Letter From the President
    • Contact

    © 2022 International Myeloma Society. All Rights Reserved - Website by Rocket Marketing.

    No Result
    View All Result
    • Contact
    • Home

    © 2022 International Myeloma Society. All Rights Reserved - Website by Rocket Marketing.